A Comment From Asthma UK On The Study 'Effect Of An Interleukin-4 Variant On Late Phase Asthmatic Response To Allergen Challenge In Asthmatic Patients

Main Category: Respiratory / Asthma
Also Included In: Allergy
Article Date: 24 Oct 2007 - 1:00 PDT

Current Article Ratings:

Patient / Public:
Healthcare Prof:

Director of the MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, Professor Tak Lee, says: 'Around half of the 5.2 million people with asthma in the UK have severe asthma because treatments currently available do not effectively control their condition, emphasising the need to discover new treatments.

'For a long time research has suggested that IL4 and IL13, either independently or together, may cause asthma, so the discovery that a drug can reduce the severity of the allergic asthmatic response by blocking their action is very exciting.

'Clearly further trials are needed now in patients with different severities of asthma to define more clearly when and how best to use the drug and to compare its effectiveness with other currently available treatments.'

http://www.asthma.org.uk

Additional
References
Citations

Article adapted by Medical News Today from original press release.
Visit our respiratory / asthma section for the latest news on this subject.

There are no references listed for this article.

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Asthma UK. "A Comment From Asthma UK On The Study 'Effect Of An Interleukin-4 Variant On Late Phase Asthmatic Response To Allergen Challenge In Asthmatic Patients." Medical News Today. MediLexicon, Intl., 24 Oct. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/86412.php>

APA

Asthma UK. (2007, October 24). "A Comment From Asthma UK On The Study 'Effect Of An Interleukin-4 Variant On Late Phase Asthmatic Response To Allergen Challenge In Asthmatic Patients." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/86412.php.

Please note: If no author information is provided, the source is cited instead.

Rate this article:
(Hover over the stars then click to rate)

Patient / Public:

Health Professional:

Add Your Opinion

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Respiratory / Asthma

What is Asthma?

Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition (long-lasting or recurrent) are said to be asthmatic. Read more...

Follow Our Respiratory News On Twitter

Get the latest news for this category delivered straight to your Twitter account. Simply visit our Respiratory / Asthma Twitter account and select the 'follow' option.

Conditions Information

View list of all 'What Is...' articles »

Your Name:*
E-mail Address:*
Title For Opinion:*
Opinion:*

This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*